Join Our Newsletter





Events Calendar

« < November 2014 > »
S M T W T F S
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6
Home arrow Marketing Research News arrow Company News And Announcements July-December 2010 arrow The Planning Shop International Announces Oncology Business Unit
The Planning Shop International Announces Oncology Business Unit Print E-mail
Written by The Planning Shop   
New business unit introduced at EphMRA in Berlin

THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area.

This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.

Oncology is a complex, fast moving therapeutic area. Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer.

Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products.

The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands.

Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.

“TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit,” said Kim Hughes, Managing Director, TPSi London. “Her joining TPSi represents the merger of deep oncology therapy knowledge with broad brand understanding, the synergies of which will provide clients with brand strategy for a fast-shifting clinical context.”

The TPSi Oncology Business Unit was established when the company recognized that most of its clients were increasingly involved in oncology -- either marketing existing compounds or developing new compounds.

According to Sherry Fox, President, TPSi North America and founder of the unit, “We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who would contribute the necessary expertise.

Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs.”

About THE PLANNING SHOP international

For more information please visit http://www.planningshop.com/

Philadelphia, PA and London, UK - 30 June 2010

 
< Prev   Next >

Polls

How important is market research to start-ups in the current economic climate?
 

RSS Feeds

Subscribe Now